An interventional study of Carbohydrate loading and Water (Placebo) in Insulin Resistance, sponsored by Gadjah Mada University. Enrolling by invitation at 1 site in Indonesia. Open to participants aged 2 Years to 16 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-01.
Sponsored by Gadjah Mada University · Not applicable, Interventional, and Other
Among 20 studies in Insulin Resistance with a site in Indonesia — 4 open to participants now, 4 under way, none of them phase 3. Insulin Resistance · Indonesia.
Among the 20 studies in Insulin Resistance with a site in Indonesia, this one is the 9th largest by planned enrollment of the 18 interventional ones that give a count, is one of 4 that started in 2024, is one of 13 with no phase, and was the 18th registered.
2,969 studies on the registry are indexed under Insulin Resistance; 338 are open to participants now.
Browse Insulin Resistance studies →4 of the 20 studies in Insulin Resistance with a site in Indonesia are open now. Recruiting first, the newest first:
Rifdhani Fakhrudin Nur · Sites in Indonesia
Andalas University · Sites in Indonesia
Andina Setyawati · Sites in Indonesia
A study can be open while its sites in Indonesia have not opened yet or have stopped. Only those recruiting at a site in Indonesia →
Of the 244 Insulin Resistance studies recruiting now, 54 (22%) set no upper age limit and 158 (65%) stop at 75 or younger; 30 take children under 18; 113 take healthy volunteers.
This study: 2 Years to 16 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
20 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 2 · Phase 3 2 · Phase 4 1
First in 2009; this study’s year is marked. 4 started in 2024.
This study's planned enrollment of 50 is above the median of 40 across 2,369 interventional studies indexed under Insulin Resistance.
Median enrollment 50 across the 18 interventional studies, 339 across the 2 observational. Of the 11 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 20 have an industry lead sponsor. The 10 most frequent:
Gadjah Mada University is the lead sponsor of 63 studies on the registry; 19 are open to participants now.
Gadjah Mada University has 1 study filed under Insulin Resistance — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 20 studies in Insulin Resistance with a site in Indonesia, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
It is a double blinded randomized controlled trial interventional study, examining the effect of carb loading given prior to surgery on preventing post operative insulin resistance in pediatric patients undergoing elective surgery
The tsudy
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Drop out Criteria:
- Intraoperative surgical emergency e.g. massive bleeding
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Subjects, at 1 hour prior to surgery, are given liquid containing Dextrose10% with osmolality of 191,92mOsm/L and energy of 34 kcal/100 cc. The dose is 3 ml/kg body weight
Other: Carbohydrate loading
Subjects, at 1 hour prior to surgery, are given just water with the dose of 3 ml/kg body weight
Other: Water (Placebo)
Subjects, at 1 hour prior to surgery, are given liquid containing Dextrose10% with osmolality of 191,92mOsm/L and energy of 34 kcal/100 cc. The dose is 3 ml/kg body weight
Subjects, at 1 hour prior to surgery, are given just water with the dose of 3 ml/kg body weight
Insulin Resistance
Insulin resistance is measured using Homeostasis Model Assessment Insulin Resistance (HOMA-IR), with the formula of (Insulin concentration x Glucose concentration)/22.5
Time frame: measured just before incision and 24 hour after surgery
Plan to share: Yes — The age of participants, glucose level, and insulin level measured will be shared
Supporting information: Study protocol, Statistical analysis plan
Time frame: Data will be available after the completion of the study
Access criteria: Everybody will be able to access the data by personally emailing the study coordinator
No publications or documents are linked to this record.
Started Jan 2024 (actual). Primary completion is estimated for Apr 2026, 27 months after the start.
Of 714 non-industry interventional studies with no phase under Insulin Resistance, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 27 months is above that.
Counting every sponsor, half of 754 studies reached it within 21 months; a quarter within 9 and three quarters within 40.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Gadjah Mada University